Saturday, February 21, 2026
31 C
Bengaluru

Doctors Day with a Difference

[wpfilebase tag=file id=113 tpl=download-button /]

Inside this Issue

1. Editorial: Doctor’s Day with a Difference!

MedicinMan reports on a unique celebration of the special day in Mangaluru, Karnataka, organized by a prominent city surgeon and professor and honoring the work of anganwadi workers, medical representatives and the District Health Officer.

2. Briefing the Design Agency: A Skill Oft-Neglected by Pharma Brand Managers by Vivek Hattangadi

The design brief can make or break a brand campaign; here’s how to get it right.

3. Indian Pharma Highlights for June 2018 by IQVIA

The Indian pharma market clocked 10,460 Crores for month of June with a robust growth at 12.8%. Here are the biggest winners.

4. Pharma’s Silver Lining Continues to Broaden by Salil Kallianpur

Salil Kallianpur, Executive Editor, MedicinMan, comments on the IQVIA numbers for June 2018

5. Pharmacology Refresher: Drugs Acting on the Nitric Oxide Pathway by Dr. Anand Lakhar

The nitric oxide pathway in the human body is key to the treatment of a variety of diseases from angina to erectile dysfunction

6. Philips Launches India’s 1st Future Health Index by Press Release

The FHI is “a research-based platform that helps to determine the readiness of countries to address global health challenges”

7. Book Review: Encyclopedia of Nobel Laureates

Download the issue here: PDF

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img